Detalhe da pesquisa
1.
Two years' experience of implementing a comprehensive telemedical stroke network comprising in mainly rural region: the Transregional Network for Stroke Intervention with Telemedicine (TRANSIT-Stroke).
BMC Neurol
; 20(1): 104, 2020 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32192438
2.
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation.
J Neurol
; 266(1): 165-173, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446966
3.
Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.
J Neurol
; 265(7): 1521-1527, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29696498
4.
Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis.
PLoS One
; 5(11): e15478, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21085578
5.
Effects of natalizumab treatment on Foxp3+ T regulatory cells.
PLoS One
; 3(10): e3319, 2008 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-18836525